Table 2.
Sepsis biomarkers, except for C-reactive protein (CRP) and procalcitonin (PCT), that have been evaluated for their prognostic value in clinical studies with more than 300 subjects
Biomarker [ref] | No. of patients | Sepsis definition | Study population | Main finding | Sensitivity/specificity (%) | AUC |
---|---|---|---|---|---|---|
Urokinase plasminogen activator receptor (uPAR) [19] | 1914 | International Sepsis Definitions Conference 2001 | Critically ill patients and patients hospitalized in internal medicine ward | Levels ≥ 12 ng/mL predicted fatal outcome within 30 days | NR/> 70% |
0.708 0.83 (when combined with APACHE II score) |
Plasminogen activator inhibitor (PAI) 1 [20] | 1790 | ACCP 1992 | Septic patients with disseminated intravascular coagulation (DIC) | Levels > 90 ng/mL predict fatal outcome within 30 days | NR (Kaplan-Meier survival functions) | NR |
Interleukin (IL)-12 [21] | 1444 | Proven peritonitis or mediastinitis and systemic inflammation signs | Surgical patients | Pre-surgery IL-12-synthesizing capability was low in patients who had fatal sepsis after operation | NR | 0.72 |
Thrombomodulin [22] | 1103 | ACCP 1992 | Critically ill patients with sepsis | Levels > 14 ng/mL can predict circulatory failure or death—gray zone between 7 and 14 ng/mL | NR (logistic regression analysis) | NR |
Syndecan-1 [22] | 1103 | ACCP 1992 | Critically ill patients with sepsis | Levels > 240 ng/mL can predict circulatory failure or death—gray zone between 70 and 240 ng/mL | NR (logistic regression analysis) | NR |
Fibrinogen [23] | 1103 | ACCP 1992 | Critically ill patients with sepsis | Levels < 200 mg/dL related to increased risk of fatal outcome | NR (logistic regression analysis) | NR |
Antithrombin activity [23] | 1103 | ACCP 1992 | Critically ill patients with sepsis | Decrease in activity > 50% related to increased risk of fatal outcome | NR (logistic regression analysis) | NR |
Brain natriuretic peptide (BNP) [24] | 1000 | International Sepsis Definition Conference 2001 | ED patients | Levels > 113 pg/mL can predict fatal outcome within 28 days | 86/55 | 0.73 |
Angiopoietin-2 [25] | 931 | NR | Critically ill patients with ARDS | Persistently increased levels related to fatal outcome within 90 days | NR (logistic regression analysis) | NR |
Prothrombin time (PT) [26] | 840 | Suspected infection plus ≥ 3 signs of systematic inflammatory response | Critically ill patients with sepsis | Increase in PT time within first 7 days of sepsis was higher in patients who died within 28 days | NR (no test) | NR |
Adrenomedullin [27] | 837 | International Sepsis Definitions Conference 2001 | ED patients sepsis | Levels < 34.4 ng/L predicted fatal outcome within 30 days | 86/61 |
0.77 0.81 (when combined with Mortality in Emergency Department Sepsis (MEDS) score) |
Pro-adrenomedullin [28] | 896 | Clinical suspicion of infection | ED patients with sepsis | Levels ≥ 1.6 nmol/L predicted fatal outcome within 28 days | 75/92 | 0.89 |
Heparin-binding protein [29] | 759 | Suspected infection and at least one clinical sign of systematic inflammatory response | ED patients with sepsis | Levels > 30 ng/mL predicted any organ dysfunction development within 72 h | 78/76 (cross-tabulation analysis) | NR |
D-dimer [30] | 684 | International Sepsis Definitions Conference 2001 | Emergency department patients with sepsis | Higher in non-survivors than survivors within 28 days | NR | 0.68 |
Troponin [31] | 598 | ACCP 1992 | Critically ill patients | Levels > 0.06 ng/mL independent prognostic marker for 28-day mortality | NR (logistic regression analysis) | NR |
YKL-40 [32] | 502 | ACCP 1992 | Critically ill patients | Levels ≤ 505 ng/mL predicted survival in 90 days | 53/76 | 0.64 |
CD64 [13] | 468 | International Sepsis Definition Conference 2001 | Critically ill patients | Sustained elevated levels were related to non-appropriate antibiotic therapy | 93/48 | 0.74 |
Cell-free DNA [33] | 481 | International Sepsis Definitions Conference 2001 | ED patients | Levels > 1.6 μg/mL predicted short-term fatal outcome | 70/76 | 0.77 |
ARDS acute respiratory distress syndrome, NR not reported, IL interleukin, SOFA sequential organ failure assessment, AUC area under the receiver operating characteristic curve